Lee Ainslie - Maverick Capital
Holding/activity history for Damora Therapeutics, Inc. (DMRA)
← All DMRA superinvestors
| Period | Shares | % of Portfolio | Activity | % Change to Portfolio | Price | Value | Filing |
|---|---|---|---|---|---|---|---|
| 2021 Q3 | 0 | 0.00 | Sell 100.00% | 0.02 | $87.75–126.75 · VW $107.86i | SEC | |
| 2021 Q2 | 14,252 | 0.02 | Reduce 26.18% | <0.01 | $112.55–410.25 · VW $165.58i | $1,803,000 | SEC |
| 2021 Q1 | 19,307 | 0.03 | Reduce 1.59% | <0.01 | $147.75–340.00 · VW $236.88i | $2,900,000 | SEC |
| 2020 Q4 | 19,618 | 0.09 | Buy | 0.09 | $289.25–449.75 · VW $382.97i IPO/listing quarter |
$5,846,000 | SEC |
Price snapshot:
Current price$28.00
52-week low$2.45
52-week high$38.33